Please provide your email address to receive an email when new articles are posted on . 45% of children with airway eosinophils had endobronchial biopsy eosinophils without bronchoalveolar lavage ...
Specific sputum markers, including higher sputum eosinophils, macrophages, and lymphocyte counts, were associated with remission after interleukin-5 (IL-5)–targeted therapy for patients with severe ...
Please provide your email address to receive an email when new articles are posted on . Reductions in eosinophil counts were observed as early as weeks 4 to 6. Absolute eosinophil counts returned to ...
China: Researchers have found in a new meta-analysis that mepolizumab is an effective and safe treatment for severe ...
Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...
Some people with very severe asthma symptoms have a condition called eosinophilic asthma. People with this type of asthma may need to use inhaled medicines along with a newer type of medicine that is ...
Treatment failures occurred in 74% and 45% of patients in the PRED and pooled BENRA groups, respectively, at 90 days. (HealthDay News) — Benralizumab can be used for the treatment of acute ...
Severe eosinophilic asthma (SEA) is a debilitating respiratory condition characterized by persistent airway inflammation and high eosinophil levels, resulting in frequent exacerbations and significant ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA expanded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results